BUDGET IMPACT AND THE COST-EFFECTIVENESS OF INTRODUCING VORETIGENE NEPARVOVEC FOR TREATING INHERITED RETINAL DISEASES IN THE KINGDOM OF SAUDI ARABIA

被引：0
|
作者：
Al Jedai, A. [1 ]
AL-Mudaiheem, H. [1 ]
Ba-Abbad, R. [2 ]
Alsulaiman, S. [2 ]
Amro, S. A. A. [3 ]
Awad, N. [4 ]
Ojeil, R.
机构：
[1] Minist Hlth, Riyadh, Saudi Arabia
[2] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia
[3] King Saud Univ, Riyadh, Saudi Arabia
[4] Carexso, Dubai, U Arab Emirates
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE238
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 28 条
  • [1] Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland
    Bhadhuri, Arjun
    Droschel, Daniel
    Guldimann, Mike
    Jetschgo, Claudia
    Banhazi, Judit
    Schwenkglenks, Matthias
    Sutherland, C. Simone
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [2] Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in Switzerland
    Arjun Bhadhuri
    Daniel Dröschel
    Mike Guldimann
    Claudia Jetschgo
    Judit Banhazi
    Matthias Schwenkglenks
    C. Simone Sutherland
    BMC Health Services Research, 22
  • [3] Cost Effectiveness of Voretigene Neparvovec for RPE65-Mediated Inherited Retinal Degeneration in Germany
    Uhrmann, Matthias Fritz
    Lorenz, Birgit
    Gissel, Christian
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2020, 9 (09): : 1 - 8
  • [4] A COST-EFFECTIVENESS ANALYSIS OF VORETIGENE NEPARVOVEC FOR VISION LOSS DUE TO BIALLELIC RPE65-MEDIATED INHERITED RETINAL DISEASE
    Zimmermann, M. R.
    Lubinga, S. J.
    Rind, D.
    Chapman, R. H.
    Carlson, J. J.
    VALUE IN HEALTH, 2018, 21 : S205 - S206
  • [5] Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease
    Johnson, Scott
    Buessing, Marric
    O'Connell, Thomas
    Pitluck, Sarah
    Ciulla, Thomas A.
    JAMA OPHTHALMOLOGY, 2019, 137 (10) : 1115 - 1123
  • [6] COST-EFFECTIVENESS OF VORETIGENE NEPARVOVEC FOR VISION LOSS DUE TO BIALLELIC RPE65-MEDIATED INHERITED RETINAL DISEASE IN A DANISH SETTING
    Ploug, U.
    VALUE IN HEALTH, 2019, 22 : S846 - S846
  • [7] Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia
    Alghamdi, Ahmed
    Balkhi, Bander
    Altowaijri, Abdulaziz
    Al-shehri, Nasser
    Ralph, Lewis
    Marriott, Emily-Ruth
    Urbich, Michael
    Aljanad, Fawaz
    Aziziyeh, Rima
    PHARMACOECONOMICS-OPEN, 2022, 6 (02) : 277 - 291
  • [8] Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia
    Ahmed Alghamdi
    Bander Balkhi
    Abdulaziz Altowaijri
    Nasser Al-shehri
    Lewis Ralph
    Emily-Ruth Marriott
    Michael Urbich
    Fawaz Aljanad
    Rima Aziziyeh
    PharmacoEconomics - Open, 2022, 6 : 277 - 291
  • [9] COST-EFFECTIVENESS OF EVOLOCUMAB FOR THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA IN THE KINGDOM OF SAUDI ARABIA
    Alghamdi, A.
    Balkhi, B.
    Altowaijri, A.
    Alshehri, N.
    AlHabib, K. F.
    Ralph, L.
    Marriott, E. R.
    Perlaza, Garcia J.
    al-Janad, F.
    Aziziyeh, R.
    VALUE IN HEALTH, 2020, 23 : S95 - S96
  • [10] The estimated cost-effectiveness of paediatric rotavirus vaccination in the Kingdom of Saudi Arabia
    Shibl, A.
    AlHasan, S.
    Standaert, B.
    Al Soghaeir, M.
    Al Aidoroos, A.
    Kandeel, W.
    Soliman, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 : E340 - E340
123